Methyl 3-(cyanoMethyl)benzoate）

UVA protection

Antidepressive

Antidepressive

Cardiovascular

Antibacterial

Antidiabetes

CAS No.960404-48-2 In-house

CAS No.1050477-31-0 Standard：In-house

CAS NO:808118-40-3 In-house

CAS No.1260141-27-2 In-house

CAS No.464-43-7 In-house

Fosfomycin Trometamol, the tromethamine salt of fosfomycin, is a broad-spectrum bactericidal antibiotic. It acts by irreversibly inhibiting the early stage of bacterial cell wall synthesis, effective against both Gram-positive and Gram-negative bacteria, with no cross-resistance to other antibiotics. Chara...

We are proud to announce that our Fosfomycin Trometamol API has officially received EU CEP certification (Certificate No. 2024-168-Rev00) from the EDQM.We warmly invite global partners to connect with us and explore new avenues for collaboration.

Dorrapharma is engaged in R&D, manufacture and market of intermediates, APls (Active Pharmaceutical Ingredients) and formulations. We own the core technology advantage in the professional area of bromination, enzyme/metal­catalyzed, nitration and hydrogenation, and obtain multiple core patents for invention. We stick to raising the value both for the company and customers, and devote ourselves completely to the technology innovation and brand build and make every effort to foster the core competence for the company with the company mission of a leading pharmaceutical integrated operator with its core competitive advantage in global market.

Commercialized and Under-Development Pipline